Acta Scientific Pharmaceutical Sciences

Review Article Volume 10 Issue 1

A Review on Analytical Techniques for the Ivacaftor

Mukthinuthalapati Mathrusri Annapurna* and Madhuri Potla

Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India

*Corresponding Author: Mukthinuthalapati Mathrusri Annapurna, Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.

Received: November 28, 2025; Published: December 31, 2025

Abstract

Ivacaftor is used for the management of cystic fibrosis. Cystic fibrosis is one of the most common life-threatening autosomal recessive disorders in the Western World. It acts as a Cystic Fibrosis Transmembrane Regulator gene potentiator, enhancing the function of the CFTR gene. A brief review of the analytical techniques such as spectrophotometry, liquid chromatography etc so far developed for the estimation of Ivacaftor were discussed in detail in the present study.

Keywords: Ivacaftor; Lungs; Liquid Chromatography

References

  1. Condren ME and Bradshaw MD. “Ivacaftor: a novel gene-based therapeutic approach for cystic fibrosis”. Journal of Pediatric Pharmacology and Therapeutics 18 (2013): 8-13.
  2. Kapoor H. “Ivacaftor: a novel mutation modulating drug”. Journal of Clinical and Diagnostic Research 11 (2014): 1-6.
  3. Janardhana Reddy., et al. “Method development and validation of Ivacaftor in bulk and pharmaceutical dosage form by UV Spectrophotometry”. International Journal of Research in Pharmaceutical Sciences4 (2018): 1048-1052.
  4. Gautam CV., et al. “Method development and validation of ivacaftor in bulk and pharmaceutical dosage form by UV-visible spectrophotometry”. Indo American Journal of Pharmaceutical Science 4 (2019): 7476-7481.
  5. Manisha D., et al. “Design and validation of a stability-indicating RP-HPLC technique for quantifying Ivacaftor in bulk and commercial formulations”. Current Pharmaceutical Analysis 21 (2025): 216-224.
  6. Roshani Singh., et al. “New cost-effective RP-HPLC method development and validation for quantitative estimation of Ivacaftor in pharmaceutical formulation”. International Journal of Pharmaceutical Sciences Review and Research 1 (2021): 52-57.
  7. Saniye Özcan., et al. “Determination of ivacaftor by liquid chromatography techniques in pharmaceutical formulation with interlaboratory comparison and characterization of five novel degradation products by high-performance liquid chromatography ion trap time-of-flight mass spectrometry”. Journal of Separation Science 46 (2023): 2201061.

Citation

Citation: Mukthinuthalapati Mathrusri Annapurna and Madhuri Potla. “A Review on Analytical Techniques for the Ivacaftor". Acta Scientific Pharmaceutical Sciences 10.1 (2026): 69-70.

Copyright

Copyright: © 2026 Mukthinuthalapati Mathrusri Annapurna and Madhuri Potla. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit manuscripts on/before February 10, 2026, for the second issue of 2026.

Contact US